13F Data
13F filer · CIK 1792126

Logos Global Management LP

San Francisco, CA · filing since Q4 2019 · last filing Aug 14, 2026
Reported value
$2.3B
+$320.0M vs prior
Positions
68
New / sold out
25 / 23
Added / reduced
18 / 19
Turnover
43.9%
buys $949.6M · sells $1.0B
Top-10 weight
48.3%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
NewBIONTECH SE+1,015,000–+$94.4M
NewVERA THERAPEUTICS INC+2,200,000–+$94.4M
AddedCELLDEX THERAPEUTICS INC NEW+1,650,000+366.7%+$61.4M
AddedABIVAX SA+349,000+51.7%+$46.5M
AddedDIANTHUS THERAPEUTICS INC+400,000+100.0%+$39.0M
NewBELITE BIO INC+250,000–+$38.5M
NewACHIEVE LIFE SCIENCE INC+5,425,000–+$35.4M
NewCOGENT BIOSCIENCES INC+900,000–+$34.8M
NewCOMPASS PATHWAYS PLC+2,250,000–+$31.8M
AddedCG ONCOLOGY INC+425,000+73.9%+$30.2M
33 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
ReducedREVOLUTION MEDICINES INC-1,300,000-65.0%$-243.5M
Sold outCENTESSA PHARMACEUTICALS PLC-2,125,000-100.0%$-84.4M
Sold outTERNS PHARMACEUTICALS INC-1,500,000-100.0%$-79.1M
Sold outCYTOKINETICS INC-875,000-100.0%$-57.7M
Sold outUNITED THERAPEUTICS CORP DEL-80,000-100.0%$-47.4M
Sold outMADRIGAL PHARMACEUTICALS INC-85,000-100.0%$-44.5M
Sold outBIOGEN INC-200,000-100.0%$-36.7M
ReducedRHYTHM PHARMACEUTICALS INC-325,000-72.2%$-36.1M
Sold outTYRA BIOSCIENCES INC-850,000-100.0%$-32.6M
ReducedIMMUNOCORE HLDGS PLC-900,000-60.0%$-28.6M
32 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2019: $405.7MQ1 2020: $262.9MQ2 2020: $500.5MQ3 2020: $781.4MQ4 2020: $1.2BQ1 2021: $1.0BQ2 2021: $1.2BQ3 2021: $1.4BQ4 2021: $969.6MQ1 2022: $771.3MQ2 2022: $545.1MQ3 2022: $813.4MQ4 2022: $853.6MQ1 2023: $698.7MQ2 2023: $735.2MQ3 2023: $749.5MQ4 2023: $1.1BQ1 2024: $1.2BQ2 2024: $2.5BQ3 2024: $926.8MQ4 2024: $854.6MQ1 2025: $562.5MQ2 2025: $903.8MQ3 2025: $1.1BQ4 2025: $1.7BQ1 2026: $2.0BQ2 2026: $2.3B
Q4 2019Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1ERASCA INCCOM12,150,000$222.6M9.58%
2ABIVAX SASPONSORED ADS1,024,000$136.5M5.87%
3REVOLUTION MEDICINES INCCOM700,000$131.1M5.64%
4IDEAYA BIOSCIENCES INCCOM3,000,000$111.8M4.81%
5BIONTECH SESPONSORED ADS1,015,000$94.4M4.07%
6VERA THERAPEUTICS INCCL A2,200,000$94.4M4.06%
7TANGO THERAPEUTICS INCCOM2,850,000$89.1M3.84%
8PRAXIS PRECISION MEDICINES ICOM NEW260,000$87.0M3.75%
9CELLDEX THERAPEUTICS INC NEWCOM NEW2,100,000$78.1M3.36%
10DIANTHUS THERAPEUTICS INCCOM800,000$78.0M3.36%
58 more rows. Subscribe for $29/month to see every row, download the data and use the API.